Intrathecal idursulfase for treating Mucopolysaccharidosis type II ID1223
Discontinued
Reference number: GID-HST10019
On receiving updated regulatory timing information from the company that markets the technology, NICE has agreed that holding a scoping workshop at this time would not be appropriate. Consequently the scoping workshop arranged for the 29 June 2018 will be cancelled and the consultation on the draft scope will not continue. The workshop and consultation will be rescheduled to take place in line with anticipated regulatory approval timings. We apologise for any inconvenience this may cause.